Exact Mass: 711.2904136000001
Exact Mass Matches: 711.2904136000001
Found 20 metabolites which its exact mass value is equals to given mass value 711.2904136000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Monoaspartyl chlorin e6
C38H41N5O9 (711.2904136000001)
Talaporfin
C38H41N5O9 (711.2904136000001)
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents
Monoaspartyl chlorin e6
C38H41N5O9 (711.2904136000001)
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents
N-(2-aminophenyl)-N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C37H47Cl2N5O5 (711.2954071999999)
N-(2-aminophenyl)-N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C37H47Cl2N5O5 (711.2954071999999)
N-(2-aminophenyl)-N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C37H47Cl2N5O5 (711.2954071999999)
(2s)-2-({[(1s)-1-{[(1s,2r)-2-[(2s)-2-amino-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,26,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25(29)-octaen-13-yl acetate
2,15,17,23,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,26,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25(29)-octaen-13-yl acetate
(7s,9e,11s,12r,13s,14r,15r,16s,17s,18e,20z,22s)-2,15,17,23,26,27-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30,31-trioxa-24-azapentacyclo[20.6.2.1⁴,⁷.0⁵,²⁸.0²⁵,²⁹]hentriaconta-1(29),2,4,9,18,20,23,25,27-nonaen-13-yl acetate
2-{[(1-{[2-(2-amino-n-methylpropanamido)-1-({[4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]amino}-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)
2-{[(1-{[2-(2-amino-n-methylpropanamido)-1-({[(2z)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]amino}-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)
(2s)-2-({[(1s)-1-{[(1s,2s)-2-[(2s)-2-amino-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)